Hutch News

Naturally killing thymus regeneration

Naturally killing thymus regeneration

From the Dudakov Lab, Translational Science and Therapeutics Division
Science SpotlightJanuary 28, 2026
Made to last: engineering durable CAR-T cells

Made to last: engineering durable CAR-T cells

From the Peterson and Kiem Labs, Translational Science and Therapeutics Division
Science SpotlightJanuary 28, 2026
Conducting RNA reconnaissance

Conducting RNA reconnaissance

Fred Hutch researchers invent a CRISPR screening method to understand RNA-binding proteins often mutated in cancer and other diseases
Hutch NewsAugust 05, 2025
‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies

‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies

Dr. Folashade Otegbeye is the recipient of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
Hutch NewsJuly 30, 2025
Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response

Patients’ own autoantibodies may hold key to boosting cancer immunotherapy response

A study published in Nature finds that some cancer patients can make their “own companion drug,” suggesting a potential template for future treatments
News ReleasesJuly 23, 2025
Age-dependent genetic alterations in AML patients

Age-dependent genetic alterations in AML patients

From the Meshinchi Lab, Translational Science & Therapeutics Division
Science SpotlightJuly 23, 2025
Premature immune aging occurs in children with leukemia

Premature immune aging occurs in children with leukemia

From Drs. Kavita Dhodapkar and Madhav Dhodapkar, Translational Science & Therapeutics Division
Science SpotlightJuly 23, 2025
Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

National award honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science
News ReleasesJune 17, 2025
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees

Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees

Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
News ReleasesJune 16, 2025
A chair built together

A chair built together

Collective fundraising effort honors Kyle Thomas Spane, fuels research in colon cancer prevention
Hutch NewsMay 06, 2025
Could fecal microbiota transplantation help patients heal after stem cell transplantation?

Could fecal microbiota transplantation help patients heal after stem cell transplantation?

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer
News ReleasesJanuary 28, 2025
50 years of doing hard things

50 years of doing hard things

Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Hutch NewsJanuary 09, 2025
In the race to replicate, it’s better to think small-scale

In the race to replicate, it’s better to think small-scale

From The Bedalov Lab, Human Biology and Translational Science and Therapeutics Divisions
Science SpotlightJanuary 09, 2025